Current Environment: Production

Camilla Richmond | Medical Services

Programs & Services

Languages

  • English

Camilla Richmond | Education

Undergraduate School

Stanford University

1999, Stanford, CA

Graduate School

Yale University

2000, New Haven, CT

Medical School

Northwestern University Feinberg School of Medicine

2004, Evanston, IL

Residency

Seattle Children's Hospital, University of Washington

2007, Seattle, WA

Fellowship

Boston Children's Hospital

2011, Boston, MA

Camilla Richmond | Certifications

  • American Board of Pediatrics (Gastroenterology)
  • American Board of Pediatrics (General)

Camilla Richmond | Publications

  1. Symptom Patterns in Adults With Cyclic Vomiting Syndrome: A 6-Month Prospective Observational Study. Neurogastroenterol Motil. 2025 Feb; 37(2):e14974. View Symptom Patterns in Adults With Cyclic Vomiting Syndrome: A 6-Month Prospective Observational Study. Abstract

  2. Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study. J Clin Pharmacol. 2025 Feb; 65(2):217-225. View Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study. Abstract

  3. Epidemiology, Comorbidities, and Treatment of Cyclic Vomiting Syndrome in the United States. Am J Gastroenterol. 2024 05 01; 119(5):965-976. View Epidemiology, Comorbidities, and Treatment of Cyclic Vomiting Syndrome in the United States. Abstract

  4. Productivity Loss and Indirect Burden of Cyclic Vomiting Syndrome in the United States. Gastro Hep Adv. 2022; 1(6):954-962. View Productivity Loss and Indirect Burden of Cyclic Vomiting Syndrome in the United States. Abstract

  5. Health Care Resource Use and Associated Costs of Cyclic Vomiting Syndrome in the United States. Gastro Hep Adv. 2022; 1(6):963-973. View Health Care Resource Use and Associated Costs of Cyclic Vomiting Syndrome in the United States. Abstract

  6. A hemodialysis patient with difficulty ambulating: Questions. Pediatr Nephrol. 2021 Jul; 36(7):2069-2070. View A hemodialysis patient with difficulty ambulating: Questions. Abstract

  7. A hemodialysis patient with difficulty ambulating: Answers. Pediatr Nephrol. 2021 Jul; 36(7):2071-2073. View A hemodialysis patient with difficulty ambulating: Answers. Abstract

  8. Human Colon-on-a-Chip Enables Continuous In Vitro Analysis of Colon Mucus Layer Accumulation and Physiology. Cell Mol Gastroenterol Hepatol. 2020; 9(3):507-526. View Human Colon-on-a-Chip Enables Continuous In Vitro Analysis of Colon Mucus Layer Accumulation and Physiology. Abstract

  9. Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites. Microbiome. 2019 03 20; 7(1):43. View Species-specific enhancement of enterohemorrhagic E. coli pathogenesis mediated by microbiome metabolites. Abstract

  10. High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue. Mucosal Immunol. 2018 11; 11(6):1684-1693. View High-dimensional immune phenotyping and transcriptional analyses reveal robust recovery of viable human immune and epithelial cells from frozen gastrointestinal tissue. Abstract

  11. Neonatal-Onset Chronic Diarrhea Caused by Homozygous Nonsense WNT2B Mutations. Am J Hum Genet. 2018 07 05; 103(1):131-137. View Neonatal-Onset Chronic Diarrhea Caused by Homozygous Nonsense WNT2B Mutations. Abstract

  12. Move Over Caco-2 Cells: Human-Induced Organoids Meet Gut-on-a-Chip. Cell Mol Gastroenterol Hepatol. 2018; 5(4):634-635. View Move Over Caco-2 Cells: Human-Induced Organoids Meet Gut-on-a-Chip. Abstract

  13. Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids. Sci Rep. 2018 02 13; 8(1):2871. View Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids. Abstract

  14. JAK/STAT-1 Signaling Is Required for Reserve Intestinal Stem Cell Activation during Intestinal Regeneration Following Acute Inflammation. Stem Cell Reports. 2018 01 09; 10(1):17-26. View JAK/STAT-1 Signaling Is Required for Reserve Intestinal Stem Cell Activation during Intestinal Regeneration Following Acute Inflammation. Abstract

  15. An enduring role for quiescent stem cells. Dev Dyn. 2016 07; 245(7):718-26. View An enduring role for quiescent stem cells. Abstract

  16. Reprogrammed Stomach Tissue as a Renewable Source of Functional ß Cells for Blood Glucose Regulation. Cell Stem Cell. 2016 Mar 03; 18(3):410-21. View Reprogrammed Stomach Tissue as a Renewable Source of Functional ß Cells for Blood Glucose Regulation. Abstract

  17. Factors regulating quiescent stem cells: insights from the intestine and other self-renewing tissues. J Physiol. 2016 09 01; 594(17):4805-13. View Factors regulating quiescent stem cells: insights from the intestine and other self-renewing tissues. Abstract

  18. Dormant Intestinal Stem Cells Are Regulated by PTEN and Nutritional Status. Cell Rep. 2015 Dec 22; 13(11):2403-2411. View Dormant Intestinal Stem Cells Are Regulated by PTEN and Nutritional Status. Abstract

  19. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A. 2011 Jan 04; 108(1):179-84. View Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Abstract

  20. Regulation of gene expression in the intestinal epithelium. Prog Mol Biol Transl Sci. 2010; 96:207-29. View Regulation of gene expression in the intestinal epithelium. Abstract

  21. Subretinal hemorrhage associated with cytomegalovirus retinitis in a patient without concurrent thrombocytopenia. Retina. 2004 Aug; 24(4):611-3. View Subretinal hemorrhage associated with cytomegalovirus retinitis in a patient without concurrent thrombocytopenia. Abstract

BESbswy